SG Americas Securities
BPMC

SG Americas Securities’s Blueprint Medicines BPMC Stock Holding History

SG Americas Securities’s Portfolio BPMC Stock Details BPMC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q3 		– Sell
-41,500
Closed -$212K – 2752
2020
Q2 		$212K Buy
+41,500
New +$2.81M ﹤0.01% 2811

Other funds holding BPMC

DekaBank Deutsche Girozentrale
DekaBank Deutsche Girozentrale Frankfurt, Germany $60.6B AUM 23.27% 1-Year Est. Return
VanEck Associates
VanEck Associates New York $133B AUM 72.99% 1-Year Est. Return
IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
Osaic Holdings
Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return
HNB
Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

SG Americas Securities's BPMC Position: Q3 2025 in Review

SG Americas Securities sold out of Blueprint Medicines (BPMC) in Q3 2025, closing a stake of 2,988 shares — an estimated $383K sold.

SG Americas Securities first reported a position in BPMC in Q4 2016 and held it in 32 quarters. The position peaked at $3.88M in Q4 2021. 5 funds tracked by Wall St. Rank hold BPMC as of Q3 2025.

  • SG Americas Securities reported no remaining Blueprint Medicines position as of Q3 2025 after selling out during the quarter.
  • SG Americas Securities sold 2,988 Blueprint Medicines shares in Q3 2025, an estimated $383K.
  • SG Americas Securities first reported a position in Blueprint Medicines in Q4 2016 and held it in 32 quarters.
  • SG Americas Securities's Blueprint Medicines position peaked at $3.88M in Q4 2021.
  • 5 funds tracked by Wall St. Rank held Blueprint Medicines as of Q3 2025.

Based on SG Americas Securities's 13F filing for Q3 2025, filed 23 Oct 2025.